Concert Pharmaceuticals, Inc.
DEUTERATED EPI-743
Last updated:
Abstract:
This invention relates to novel .alpha.-tocotrienol quinones of Formula I: (I), and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering Vitamin E. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
18 Nov 2016
Issue date:
2 Sep 2021